Non-contrast pCASL detected SE-related peri-ictal perfusion abnormalities and showed significant quantitative correspondence with DSC-derived CBF and CBV in parenchymal hyperperfusion, supporting its use as a pragmatic approach for clinically oriented evaluation.
Lukas Machegger, Pilar Bosque Varela, J. Steinbacher et al.· Epilepsia· 0 citations
Importance
Concomitant use of antiseizure medications (ASMs) and direct oral anticoagulants (DOACs) is common in epilepsy, but comparative safety data remain limited.
Objective
To compare risks of thromboembolic events, major bleeding, and all-cause mortality across commonly used ASMs in adults with epilepsy receivin...
K. Schubert, C. Ferreira-Atuesta, Arunachalam Soma et al.· JAMA Neurology· 0 citations
Background/Aims: Magnetic Resonance Diffusion Tensor Imaging (MR-DTI) enables in vivo visualization of spinal cord white matter integrity and may provide complementary diagnostic information beyond conventional MRI. Despite its potential, clinical application in spinal cord pathology remains limited due to technical ch...
Stefan Leis, F. Klausner, M. McCoy et al.· Paracelsus Proceedings of Ex...· 0 citations
Abstract Objective Patterns within the ictal–interictal continuum (IIC) are frequently encountered in critically ill patients undergoing continuous electroencephalographic studies and may reflect ongoing ictal activity or secondary brain injury. Peri‐ictal neuroimaging abnormalities (PNA) have been described in associa...
Heterogeneity exists within the spectrum of acute symptomatic causes; distinct etiological subcategories may carry different risks of refractoriness and superrefractoriness.
Simona Lattanzi, G. Giovannini, Niccolò Orlandi et al.· Epilepsia· 2 citations· ⚡1
Overall, the presence of SCSs alone was not associated with a poor outcome, but the spatial non-concordance with the seizure-onset zone was highly predictive for poor seizure outcome.
P. Bosque-Varela, Panagiota-Eleni Tsalouchidou, Petra Levicka et al.· Epilepsia· 0 citations
The ACARD score is a user-friendly tool developed to predict 30-day mortality after nonhypoxic SE and has the potential to identify participants at high risk of short-term mortality and outperform the performance of other available scoring systems.
Simona Lattanzi, E. Trinka, P. Bosque-Varela et al.· Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
